drugset / Trial / NCT01624064
Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Enalapril would significantly reduce progression of renal disease in patients with Chronic Kidney Disease of Uncertain aetiology.
Timeline
- Start
- 2012-08
- Primary completion
- 2012-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Calcium lactate | Small molecule | 2.5 mg | — |
| Comparator | Calcium lactate | Small molecule | 20 mg | — |
| Comparator | Enalapril | Other / unclassified | 2.5 mg | — |
| Comparator | Enalapril | Other / unclassified | 20 mg | — |